Nobl
Nobl is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Nobl.
Nobl is a company.
Key people at Nobl.
Key people at Nobl.
NOBL is the ProShares S&P 500 Dividend Aristocrats ETF, an exchange-traded fund launched on October 9, 2013, that tracks the S&P 500 Dividend Aristocrats Index.[1][3] This equal-weighted index includes S&P 500 companies that have increased their dividends annually for at least 25 consecutive years, currently comprising 69 holdings with stable earnings, solid fundamentals, and strong profitability histories.[1][3][4] As of late 2025, NOBL manages $11.18 billion in assets, features a 0.35% expense ratio, a 2.09% dividend yield (TTM), and top holdings like Cardinal Health (1.87%), Albemarle (1.81%), and C.H. Robinson (1.72%).[1][3]
The ETF's mission centers on delivering consistent dividend growth and lower volatility compared to the broader S&P 500, serving income-focused investors seeking diversification away from high-concentration tech stocks like the Magnificent Seven.[4] Its philosophy emphasizes equal weighting and quarterly rebalancing to mitigate single-stock risk, yielding about 2.5%—higher than standard S&P 500 ETFs—while prioritizing companies with proven resilience.[3][4]
NOBL was introduced by ProShares on October 9, 2013, as the first and only U.S. ETF dedicated to the S&P 500 Dividend Aristocrats Index, created by S&P Dow Jones Indices to spotlight high-quality, dividend-growing large-caps.[1][3][4] ProShares, known for innovative ETF strategies, launched NOBL amid growing demand for income-generating products post-financial crisis, targeting investors wary of market volatility.[1]
The underlying index evolved from the concept of "Dividend Aristocrats," formalized to track S&P 500 firms with 25+ years of annual dividend hikes, with periodic reconstitutions adding stalwarts like Coca-Cola, Procter & Gamble, Walmart, Erie Indemnity, Eversource Energy, and FactSet Research Systems.[4] NOBL's focus has remained steady, adapting to index changes while maintaining its equal-weight structure for balanced exposure.[1][3]
NOBL rides the trend of dividend investing amid tech dominance, countering the S&P 500's heavy reliance on the Magnificent Seven, which drove outsized returns but amplified volatility and concentration risks.[4] Its timing aligns with investor shifts toward quality, resilient names—especially post-2022 rate hikes—favoring stable earners over growth speculation.[4]
Market forces like aging demographics seeking income, potential economic slowdowns, and deglobalization boost Aristocrats' appeal, as these firms span sectors like consumer goods, healthcare, and industrials with global footprints.[3][4] NOBL influences the ecosystem by popularizing equal-weight strategies, inspiring similar funds, and highlighting dividend growth as a benchmark for corporate maturity in a tech-saturated market.[1][4]
NOBL's trajectory points to steady growth for income-oriented portfolios, potentially closing the performance gap with the S&P 500 as interest rates stabilize and value rotates from tech.[4] Rising trends like AI-driven efficiencies in holdings (e.g., FactSet) and sustained dividend cultures could enhance returns, while index expansions maintain its 69-company resilience.[3][4]
Influence may evolve as a core diversifier in multi-asset strategies, with its low-beta profile shining in downturns; expect continued quarterly rebalancing to adapt to Aristocrat additions amid economic cycles. This positions NOBL as a timeless anchor for dividend reliability in volatile markets.[1][3][4]
